Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 80.0% in March

Bluejay Diagnostics, Inc. (NASDAQ:BJDXGet Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,000 shares, a drop of 80.0% from the February 28th total of 30,000 shares. Based on an average daily volume of 82,900 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.1% of the company’s stock are short sold.

Bluejay Diagnostics Stock Performance

Shares of NASDAQ BJDX traded down $0.11 during mid-day trading on Wednesday, hitting $3.73. 27,193 shares of the stock traded hands, compared to its average volume of 192,197. The stock has a fifty day moving average price of $3.82 and a 200-day moving average price of $4.59. The company has a market cap of $2.06 million, a price-to-earnings ratio of 0.00 and a beta of 0.38. Bluejay Diagnostics has a 52 week low of $3.03 and a 52 week high of $323.92.

Institutional Investors Weigh In On Bluejay Diagnostics

A hedge fund recently raised its stake in Bluejay Diagnostics stock. Anson Funds Management LP increased its holdings in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDXFree Report) by 359.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 319,280 shares of the company’s stock after purchasing an additional 249,770 shares during the quarter. Anson Funds Management LP owned 1.93% of Bluejay Diagnostics worth $41,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 18.47% of the stock is currently owned by institutional investors.

About Bluejay Diagnostics

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

See Also

Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.